Delivery Order SPE2DB20D3103-SPE2DB22FM7L2
- Not listed
- This federal contract award is for the delivery of pharmaceutical products, specifically the HIV medication Biktarvy, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc., and has a ceiling value of $9,712.31. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,815.46 firm-fixed-price delivery order contract is for the supply of the HIV medication Biktarvy, with a period of performance through May 14, 2025. The contract is not set aside and was awarded as part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $19,671.99 firm fixed price contract is for the delivery of the HIV medication BIKTARVY 50-200-25 MG TABLET in 30-count packages. This award is a part of Amerisourcebergen Drug Corp's existing indefinite delivery contract (IDC) with DLA, valued at up to...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of the HIV medication Biktarvy 50-200-25 mg tablet. The $26,557.84 firm fixed-price delivery order has a completion date of July 24, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a wide range of pharmaceutical products and medical supplies to support military...
- This federal contract award is for the delivery of pharmaceutical products, including the anti-HIV medication Biktarvy, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which is also a registered federal contractor. The contract, valued at $105,858.88, is a firm-fixed-price delivery order that was...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the Amerisourcebergen Corporation. The $13,719.72 Firm Fixed Price Delivery Order is for the supply of the prescription medication Biktarvy, a treatment for HIV. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999.00 through December...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The award, with a ceiling value of $7,175.27, is for the delivery of the HIV treatment medication Biktarvy. The contract is a Firm Fixed Price Delivery Order and does not have any set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $102,220.74 delivery order contract is for the supply of pharmaceutical products, including the HIV medication Biktarvy 50-200-25 mg tablets. The contract has a period of performance ending on January 24, 2024 and utilizes a firm fixed price pricing structure. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $22,982.83 delivery order covers the supply of Biktarvy 50-200-25 30S, a prescription medication, to support military healthcare programs. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company...
- This federal contract award, valued at $8,531.99, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under a broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FM7L2Delivery Order
The federal contract award, number SPE2DB20D3103|SPE2DB22FM7L2, was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $59,841.99 firm fixed-price delivery order is for the supply of the HIV medication Biktarvy. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs worldwide. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen has also secured a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.